# Best Available Therapy With or Without Meropenem for Bloodstream Infections by Enterobacterales With High Level of Resistance to Carbapenems

> **NCT04876430** · PHASE2,PHASE3 · TERMINATED · sponsor: **Hospital de Clinicas de Porto Alegre** · enrollment: 13 (actual)

## Conditions studied

- Carbapenem-Resistant Enterobacteriaceae Infection
- Bloodstream Infection

## Interventions

- **DRUG:** Meropenem

## Key facts

- **NCT ID:** NCT04876430
- **Lead sponsor:** Hospital de Clinicas de Porto Alegre
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-05-04
- **Primary completion:** 2022-03-07
- **Final completion:** 2022-03-07
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** Very low frequency of recruitment
- **Last updated:** 2022-08-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04876430

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04876430, "Best Available Therapy With or Without Meropenem for Bloodstream Infections by Enterobacterales With High Level of Resistance to Carbapenems". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04876430. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*